Comments on the Background Document on Propylparaben and Butylparaben in Skin-Applied Leave-On Products Share page: Download Document Issues: OTC Medicines Sunscreen Related Posts Press Releases and Statements CHPA Commends Lawmakers for Urging FDA to Protect the Rx-OTC-Switch Pathway Apr 11, 2025 Press Releases and Statements House Leaders Prioritize OMUFA Renewal, CHPA Welcomes Progress Apr 1, 2025 Press Releases and Statements CHPA Statement on Senate Confirmation of Dr. Makary as FDA Commissioner Mar 25, 2025